Fantastic to share new work led by Sarah Whiteside published today in Science Immunology. We find that CD4+ conventional T cells acquire suppressive functions upon Treg depletion limiting efficacy of Treg-targeted therapies. Collaboration with Lugli Lab🧵👇 science.org/doi/10.1126/sc…

Our study on somatic hypermutation induced lymphoma progression #enhancers #promoters #lymphoma #SHM #rRNA #AID nature.com/articles/s4158… Thank you Columbia & VP&S for a nice coverage. Columbia Vagelos College of Physicians & Surgeons Herbert Irving Comprehensive Cancer Center ----- What Makes Lymphoma Turn Lethal? cuimc.columbia.edu/news/what-make…

We are very excited to present the development of Zman-seq (“Zman”, Hebrew for “time”), the 1st technology that measures single-cell transcriptomes and physical time in vivo, led by Daniel Kirschenbaum, Ken Xie, Florian Ingelfinger, Assaf Weiner sciencedirect.com/science/articl…. (1/19)

.EmelineJ, asdejean et al. Infinity Toulouse reveal a new mechanism whereby the transcription factor Eomes promotes CD4+ T cell accumulation in inflamed tissue thru. increased mitochondrial functions & resistance to cell death hubs.la/Q02fC_Xx0 MF Michieletto Sarry Lab LYACTS-CIRI

ARTR-seq uses antibody-guided in situ reverse transcription to efficiently, accurately identify RNA-binding protein target sites. The University of Chicago nature.com/articles/s4159…

Join Us !

Another open postion at Infinity Toulouse : Inserm Chair in Biotherapy The position is offered on a fixed-term contract (5 years) with a view to tenure as Inserm Research Director at the end of the contract More information here: eva3-accueil.inserm.fr/sites/eva/chai…

Many open positions right now Infinity Toulouse CNRS 🌍 Inserm UT3 Paul Sabatier - 2 Assistant professor positions (Immunology/ Biochemistry-Metabolism) with UT3 Paul Sabatier - 1 Chair in Biotherapy with Inserm And still a call for Group leaders more information on previous posts!

You still have time to apply! The deadline has been extended until May 15th Infinity Toulouse Inserm CNRS 🌍 UT3 Paul Sabatier

Do you want to pursue your ideas in computational biology independently, running your group in EMBL ‘s uniquely collaborative environment, next to world’s most comprehensive molecular data resources + with top-notch infrastructure EMBL-EBI? Apply to join us & pls RT

It's that time of the year in which we recruit the next generation of scientists for their training... No matter the background as far you love immunology and the 🇫🇷 culture, we have two offers to fill in... Check at ed-bsb.univ-toulouse.fr/as/ed/voirprop… and ed-bsb.univ-toulouse.fr/as/ed/voirprop…

In LSA's Immunology Collection: RNA helicase EIF4A1-mediated translation is essential for the GC response Babraham Institute Martin Turner hubs.la/Q02vG4650

Remember to get in touch soon if interested (by the end of next week at the latest!) Excellent PhD opportunity for deep learning project in bioinformatics and oncology. BSC-CNS BU_CNIO now in Bluesky: @bioinformatics.cnio.es SysBioCurie @LauCan88 CARe Graduate School Infinity Toulouse @RestoreInstitut

Have you ever wondered what Ki67 does beyond a proliferation marker? Checkout our paper in JExpMed looking at the role of Ki67 in lymphocyte development for the first time! Translational Medicine at Monash University

There is still time to join us Infinity Toulouse Inserm in an exciting programme combining cancer immunology, signalling and post-transcriptional regulation. Just contact us to know more.

Happy to share our new piece of work! Here we show how post-transcriptional regulation controls quiescence to keep naive T cells in good shape. Big collaborative effort from a wonderful lovely team 👩‍🔬👩🏾‍🔬👩🏽‍🔬🧑🏽‍🔬!!!! biorxiv.org/content/10.110…

Joyful to share another piece showing how post-transcriptional regulation controls immune cell homeostasis. This time, "the holding many secrets" innate B-1 cells and the protein HuR. A magnificent work led by Dunja and my wonderful team 👩🏽‍🔬👩‍🔬🧑🏽‍🔬👨‍🔬 biorxiv.org/content/10.110…

New research assistant position in the lab. If you enjoy Immunology 👩🏽‍🔬👨🏽‍🔬 and RNA biology 🧬, and love to play with cutting-edge technologies, please check this out.

Infinity Toulouse UT3 Paul Sabatier CNRS 🌍 Inserm est seul laboratoire d'accueil pour un poste de maître de conférences en Virologie (section 65) qui va ouvrir au concours en 2025 à l'Université de Toulouse (UT3 Paul Sabatier). Les candidatures seront ouvertes à partir du 3 mars 2025

Infinity Toulouse UT3 Paul Sabatier CNRS 🌍 Inserm est laboratoire d'accueil, avec @IpbsToulouse et CBI Toulouse , pour un poste de maître de conférences en Biochimie (section 64) qui va ouvrir au concours en 2025 UT3 Paul Sabatier Les candidatures seront ouvertes le 3 mars 2025.